Keywords: corticosteroid; H1N1; influenza; oseltamivir; peramivir;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Influenza; Lower respiratory tract complications; Peramivir;
Keywords: Assay standardization; Neuraminidase inhibition; Oseltamivir; Zanamivir; Peramivir
Keywords: Influenza; Post-marketing surveillance; Peramivir; High risk; Safety profile;
Keywords: Peramivir; Influenza virus neuraminidase inhibitor; Derivatization; Liquid chromatography–tandem mass spectrometric method (LC–MS/MS); Dog plasma
Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014-2015 to 2016-2017 influenza seasons in Japan
Keywords: Oseltamivir; Zanamivir; Laninamivir; Peramivir; Influenza A; Influenza B;
Acylguanidine derivatives of zanamivir and oseltamivir: Potential orally available prodrugs against influenza viruses
Keywords: Acylguanidine; Zanamivir; Oseltamivir; Neuraminidase inhibitor; Influenza; Arg; arginine; Boc; tert-butoxycarbonyl; (Boc)2O; di(tert-butyl) dicarbonate; CC50; half maximal cytotoxicity concentration; CPE; cytopathic effect; DIEA; diisopropyl ethylamine; D
Peramivir conjugates as orally available agents against influenza H275Y mutant
Keywords: Peramivir; Caffeic acid; Conjugate; Neuraminidase; Inhibitor; Influenza; Drug resistance; Ala; alanine; All; allyl; Asn; asparagine; Asp; aspartic acid; CDI; 1,1â²-carbonyl diimidazole; DIBAL-H; diisobutylaluminium hydride; DMAP; 4-dimethylaminopyridine;
In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2015-16 season: Comparison with the 2010-11 to 2014-15 seasons
Keywords: Influenza; 50% inhibitory concentration; Oseltamivir; Zanamivir; Laninamivir; Peramivir;
Therapeutic efficacy of peramivir against H5N1 highly pathogenic avian influenza viruses harboring the neuraminidase H275Y mutation
Keywords: Influenza; H5N1; HPAI; Peramivir; NAI; Mouse model; HPAI; highly pathogenic avian influenza; NA; neuraminidase; NAI; neuraminidase inhibitor; HK483; A/Hong Kong/483/1997 strain; HK483/H275Y; A/Hong Kong/483/1997 strain with H275Y mutation in NA; MDCK; Mad
A novel synthetic approach to the racemic Neuraminidase inhibitor Peramivir
Keywords: Peramivir; Neuraminidase inhibitor; Bicyclo[2.2.1]hepta-2,5-diene; 1,3-Dipolar cycloaddition;
In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012–2013 season
Keywords: Influenza; 50% inhibitory concentration; Oseltamivir; Zanamivir; Laninamivir; Peramivir
In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013–2014 season
Keywords: Influenza; 50% Inhibitory concentration; Oseltamivir; Zanamivir; Laninamivir; Peramivir
Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae
Keywords: Bacterial co-infection; Neuraminidase inhibitor; Peramivir; Influenza virus; Streptococcus pneumoniae;
Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (II): A pediatric drug use investigation
Keywords: Influenza; Post-marketing surveillance; Peramivir; Pediatric; Safety profile; Abnormal behavior
In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011–2012 season in Japan
Keywords: Influenza; 50% Inhibitory concentration; Oseltamivir; Zanamivir; Laninamivir; Peramivir
Viral genome and antiviral drug sensitivity analysis of two patients from a family cluster caused by the influenza A(H7N9) virus in Zhejiang, China, 2013
Keywords: Influenza; H7N9; Human-to-human transmission; Oseltamivir; Peramivir; Drug sensitivity
The relationship between in vivo antiviral activity and pharmacokinetic parameters of peramivir in influenza virus infection model in mice
Keywords: PK; pharmacokinetic; IV; intravenous; PD; pharmacodynamic; AUC; area under the concentration-time curve; Cmax; maximum concentration; IC50; 50% inhibitory concentration; IC95; 95% inhibitory concentration; T>IC95; time that drug concentration exceeds IC
Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (I): A drug use investigation
Keywords: Influenza; Peramivir; Post-marketing surveillance; Safety profile;
Neuraminidase inhibitors for influenza B virus infection: Efficacy and resistance
Keywords: Influenza B virus; Neuraminidase inhibitors; Antiviral drug resistance; Oseltamivir; Zanamivir; Peramivir;
Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009–2010 and 2010–2011 influenza seasons in Japan
Keywords: Influenza; Half maximal inhibitory concentration (IC50); Oseltamivir; Zanamivir; Peramivir; Laninamivir
Efficacy of a single intravenous dose of the neuraminidase inhibitor peramivir in the treatment of equine influenza
Keywords: Equine influenza; H3N8; Neuraminidase; Neuraminidase inhibitor; Peramivir;
Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice
Keywords: Drug combination; Favipiravir; T-705; Peramivir; Antiviral
Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme
Keywords: Peramivir; Oseltamivir carboxylate; Binding affinity; Enzyme–inhibitor complex; Neuraminidase (NA)
The de-guanidinylated derivative of peramivir remains a potent inhibitor of influenza neuraminidase
Keywords: Neuraminidase; Inhibitor; Oral availability; Influenza; Peramivir; Guanidine
A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice
Keywords: Peramivir; Influenza; Mouse model; Intramuscular; Pandemic
Widespread use of neuraminidase inhibitors in Japan
Keywords: Influenza; Pandemic; Neuraminidase inhibitor; Peramivir; Laninamivir; Oseltamivir; Zanamivir;
Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model
Keywords: Peramivir; Influenza; Mouse model; Intramuscular; Rimantadine; Combination therapy
Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice
Keywords: Drug combination; Oseltamivir carboxylate; Peramivir; Synergy; Antiviral
Host cell selection of influenza neuraminidase variants: Implications for drug resistance monitoring in A(H1N1) viruses
Keywords: Cell culture; Antiviral resistance; Tamiflu; Relenza; Peramivir; A-315675
Quantification of peramivir (a novel anti-influenza drug) in human plasma by hydrophilic interaction chromatography/tandem mass spectrometry
Keywords: Hydrophilic interaction chromatography (HILIC); Tandem mass spectrometry; TSK gel Amide-80 column; Peramivir; Neuraminidase inhibitor; Avian influenza;
Development and validation of a high-throughput zwitterionic hydrophilic interaction liquid chromatography solid-phase extraction–liquid chromatography–tandem mass spectrometry method for determination of the anti-influenza drug peramivir in plasma
Keywords: Avian influenza; Birdflu; High-throughput; HILIC; Ion suppression; Liquid chromatography/tandem mass spectrometry (LC/MS/MS); Peramivir; Solid phase extraction; Stable isotope labeled (SIL) internal standard
Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice
Keywords: Peramivir; Neuraminidase inhibitor; H5N1 influenza virus; Antibody; Parenteral administration
Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)
Keywords: Influenza A virus; Avian influenza; Pathogenicity; Antiviral agents; Animal model; Virulence; Peramivir
Current and future antiviral therapy of severe seasonal and avian influenza
Keywords: Influenza; Influenza virus; Avian influenza; H5N1 influenza virus; Adamantane; Neuraminidase; Peramivir; Oseltamivir; Zanamivir; Antiviral therapy
Anti-influenza virus activity of peramivir in mice with single intramuscular injection
Keywords: Peramivir; Influenza; Mouse model; Intramuscular